KHAN Technology Transfer Fund
KHAN-I is a €70M early-stage life sciences VC fund in Europe, partnering with academics to develop first-in-class therapies for high unmet medical needs.
Funding Stage: Series A/B
Investor type: VC Firm
Investment Areas: Med-Tech, Health-Tech, Bio-Tech
Country: Germany
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.